• Xenetic Biosciences’ research will feature in an oral presentation at the 68th ASH Annual Meeting, December 12-15, 2026, in New Orleans.
• Alexey Stepanov will present December 12, 4:00-4:15 p.m. Central Time, on DNase I’s potential to reverse CAR T-cell resistance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenetic Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202611040920ACCESSWRNAPR_____1246157) on November 04, 2026, and is solely responsible for the information contained therein.